Synthility logoSynthility
    TeamAboutContact

    Synthility / AI chemistry

    Maximise Chemistry Output From Your CROs

    Built for biotech teams outsourcing chemistry to CROs, Synthility replaces PowerPoint, spreadsheets and email with one AI-powered platform to streamline workflows, improve visibility, and maximise chemistry output from the same resources.

    Our solution

    Scale chemistry expertise across every program.

    Modern drug design can generate more promising molecules than ever before, but the software supporting complex in-lab chemistry campaigns has not moved beyond slide decks, spreadsheets and email. Synthility is building an ecosystem of connected tools to replace this legacy operating system, uniting biotech teams, CROs, data and AI to maximise chemistry output, eliminate manual admin tasks, and accelerate the path from molecular design to patented molecules.

    Synthility
    Synthility
    Use Synthility day-to-day to plan, prioritise and monitor chemistry campaigns, from individual synthetic steps to programme-wide progress. Work packages are assigned directly to the right people, while chemistry data is captured as work happens, enabling AI to automate routine tasks and improve decision-making.
    PatentFast
    PatentFast
    Use PatentFast to turn hundreds of CRO experimental reports into a consistent, patent-ready document in hours rather than weeks. AI and automation handle the tedious work, while scientists stay in control to review, refine and approve the final output.

    The team

    Meet the team

    Alex, CEO

    Alex

    CEO

    Alex is a PhD chemist with drug discovery chemistry experience, focusing in recent years on targeted protein degradation. As CEO, he oversees scientific strategy, customer discovery and commercial direction.

    Coran, CTO

    Coran

    CTO

    Coran is a veteran engineer with 10+ years building life sciences software, Coran specializes in robust platforms for modern discovery workflows. As CTO, he oversees technical architecture and product development.

    About

    About Synthility

    Drug discovery has transformed. Chemistry execution has not.

    Advances in molecular design and AI have accelerated the evaluation of small-molecule drug candidates. Yet chemistry execution remains heavily dependent on PowerPoint, spreadsheets, email and manual data handling. We experienced this first-hand in biotech: highly trained scientists spent days each week coordinating outsourced chemistry, while lab chemists lost valuable time to duplicated write-ups, unsuitable tools and poor coordination.

    We founded Synthility to solve this by building mission-critical infrastructure for drug discovery chemistry, connecting scientists, CROs, data and AI to maximise chemistry output, automate repetitive work, and accelerate the path from molecular design to patented discoveries.

    AI is rapidly removing the limits on how many molecules we can design. The next challenge is turning those designs into high-quality chemistry at scale. Skilled chemists will remain central to this process, so our opportunity is to use AI to remove the repetitive work around them and amplify their expertise.

    We are not trying to replace chemists. We are building the technology that allows their expertise to go further.

    Innovation at Scale

    Contact

    Get Early Access

    See how Synthility could help your team get more chemistry from your CROs.

    Contact Information

    info@synthility.com
    Cambridge, UK

    © 2026 Synthility Solutions Ltd. All rights reserved.